Skip to main content
Log in

Congenital cytomegalovirus infection: contribution and best timing of prenatal MR imaging

  • Magnetic Resonance
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objective

To predict sensorineural hearing loss (SNHL) and neurological impairment in congenital cytomegalovirus (cCMV) infection using MR imaging and define the best timing in pregnancy for prenatal assessment.

Methods

In 121 patients with confirmed cCMV infection, brain features at MR imaging were respectively graded from 1 to 5: normal; isolated frontal/parieto–occipital hyperintensity; temporal periventricular hyperintensity; temporal/occipital cysts and/or intraventricular septa; migration disorders. Grading was correlated with postnatal SNHL and neurological impairment using regression analysis. In 51 fetuses with MR examinations at 26.9 and 33.0 weeks, the predictive value of SNHL and neurological impairment was compared using ROC curves.

Results

Postnatal follow-up showed SNHL in 18 infants and neurological impairment in 10. MR grading was predictive of SNHL and of neurological impairment (P < 0.001). In grade 1 or 2, none had SNHL and 1/74 had neurological impairment. The areas under ROC curves for prediction of postnatal SNHL and of neurological impairment from first and second MR examination were comparable.

Conclusion

Our data suggest that in cCMV infection, prediction of SNHL and neurological impairment is feasible by fetal MR imaging with a high negative predictive value and can equally be done at 27 or 33 weeks of gestation.

Key points

In cCMV, isolated periventricular T2-weighted signal hyperintensity has a good postnatal prognosis.

In cCMV, SNHL and neurological impairment can be predicted at 27 or 33 weeks.

In cCMV, fetal MR has a high NPV in predicting SNHL.

In cCMV, fetal MR has a high NPV in predicting neurological impairment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17:253–276

    Article  PubMed  Google Scholar 

  2. Stagno S, Pass RF, Cloud G et al (1986) Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 256:1904–1908

    Article  CAS  PubMed  Google Scholar 

  3. Nance WE, Lim BG, Dodson KM (2006) Importance of congenital cytomegalovirus infections as a cause for pre-lingual hearing loss. J Clin Virol 35:221–225

    Article  PubMed  Google Scholar 

  4. Iwasaki S, Yamashita M, Maeda M, Misawa K, Mineta H (2007) Audiological outcome of infants with congenital cytomegalovirus infection in a prospective study. Audiol Neurootol 12:31–36

    Article  PubMed  Google Scholar 

  5. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S (2006) Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 35:216–220

    Article  PubMed  Google Scholar 

  6. Foulon I, Naessens A, Foulon W, Casteels A, Gordts F (2008) Hearing loss in children with congenital cytomegalovirus infection in relation to the maternal trimester in which the maternal primary infection occurred. Pediatrics 122:e1123–e1127

    Article  PubMed  Google Scholar 

  7. Enders G, Daiminger A, Bäder U, Exler S, Enders M (2011) Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol 52:244–246

    Article  PubMed  Google Scholar 

  8. Lipitz S, Yinon Y, Malinger G et al (2013) Risk of cytomegalovirus-associated sequelae in relation to time of infection and findings on prenatal imaging. Ultrasound Obstet Gynecol 41:508–514

    Article  CAS  PubMed  Google Scholar 

  9. Benoist G, Salomon LJ, Mohlo M, Suarez B, Jacquemard F, Ville Y (2008) Cytomegalovirus-related fetal brain lesions: comparison between targeted ultrasound examination and magnetic resonance imaging. Ultrasound Obstet Gynecol 32:900–905

    Article  CAS  PubMed  Google Scholar 

  10. Picone O, Simon I, Benachi A, Brunelle F, Sonigo P (2008) Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection. Prenat Diagn 28:753–758

    Article  PubMed  Google Scholar 

  11. Lipitz S, Hoffmann C, Feldman B, Tepperberg-Dikawa M, Schiff E, Weisz B (2010) Value of prenatal ultrasound and magnetic resonance imaging in assessment of congenital primary cytomegalovirus infection. Ultrasound Obstet Gynecol 36:709–717

    Article  CAS  PubMed  Google Scholar 

  12. Doneda C, Parazzini C, Righini A et al (2010) Early cerebral lesions in cytomegalovirus infection: prenatal MR imaging. Radiology 255:613–621

    Article  PubMed  Google Scholar 

  13. van der Knaap MS, Vermeulen G, Barkhof F, Hart AA, Loeber JG, Weel JF (2004) Pattern of white matter abnormalities at MR imaging: use of polymerase chain reaction testing of Guthrie cards to link pattern with congenital cytomegalovirus infection. Radiology 230:529–536

    Article  PubMed  Google Scholar 

  14. Tilea B, Alberti C, Adamsbaum C et al (2009) Cerebral biometry in fetal magnetic resonance imaging: new reference data. Ultrasound Obstet Gynecol 33:173–181

    Article  CAS  PubMed  Google Scholar 

  15. Parazzini C, Righini A, Rustico M, Consonni D, Triulzi F (2008) Prenatal magnetic resonance imaging: brain normal linear biometric values below 24 gestational weeks. Neuroradiology 50:877–883

    Article  CAS  PubMed  Google Scholar 

  16. Bayley N (2006) Screening Test of Bayley Scales of Infant and Toddler Development-III. San Antonio, Pearson

    Google Scholar 

  17. Brandt I (2001) Griffiths Entwicklungsskalen (GES) zur Beurteilung der Entwicklung in den ersten beiden Lebensjahren. Hogrefe-Verlag

  18. Snijders JT, Snijders-Oomen N (1976) Snijders-Oomen non-verbal intelligence scale, S.O.N. 21/ –7. HD 2 Tjeenk Willink, Groningen

    Google Scholar 

  19. Wechsler D (2002) WPPSI-III administration and scoring manual. Psychological Corporation, San Antonio

    Google Scholar 

  20. Wechsler D (2002) WPPSI-III technical and interpretive manual. Psychological Corporation, San Antonio

    Google Scholar 

  21. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174

    Article  CAS  PubMed  Google Scholar 

  22. Widmalm SE, Brooks SL, Sano T, Upton LG, McKay DC (2006) Limitation of the diagnostic value of MR images for diagnosing temporomandibular joint disorders. Dentomaxillofac Radiol 35:334–338

    Article  CAS  PubMed  Google Scholar 

  23. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36

    Article  CAS  PubMed  Google Scholar 

  24. Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839–843

    Article  CAS  PubMed  Google Scholar 

  25. Foulon I, Naessens A, Faron G, Foulon W, Jansen AC, Gordts F (2012) Hearing thresholds in children with a congenital CMV infection: a prospective study. Int J Pediatr Otorhinolaryngol 76:712–717

    Article  PubMed  Google Scholar 

  26. Yoshinaga-Itano C, Sedey AL, Coulter DK, Mehl AL (1998) Language of early- and later-identified children with hearing loss. Pediatrics 102:1161–1171

    Article  CAS  PubMed  Google Scholar 

  27. Bernal B, Perdomo J. Brodmann’s Interactive Atlas 1.1. http://www.fmriconsulting.com/brodmann/

  28. Cheeran MC, Lokensgard JR, Schleiss MR (2009) Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev 22:99–126

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Marques Dias MJ, Harmant-van Rijckevorsel G, Landrieu P, Lyon G (1984) Prenatal cytomegalovirus disease and cerebral microgyria: evidence for perfusion failure, not disturbance of histogenesis, as the major cause of fetal cytomegalovirus encephalopathy. Neuropediatrics 15:18–24

    Article  CAS  PubMed  Google Scholar 

  30. Jacquemard F, Yamamoto M, Costa JM et al (2007) Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 114:1113–1121

    Article  CAS  PubMed  Google Scholar 

  31. Ville Y. In utero treatment of cytomegalovirus congenital infection with valacyclovir (CYMEVAL). NIH-Clinical trials 2012. http://clinicaltrials.gov/ct2/show/NCT01651585?term=Cytomegalovirus++congenital&recr=Open&rank=8

  32. Spong CY, Thom E. A randomized trial to prevent congenital cytomegalovirus (CMV). NIH Clinical trials 2012. http://clinicaltrials.gov/ct2/show/NCT01376778?term=Cytomegalovirus++congenital&recr=Open&rank=3

  33. Walker SP, Palma-Dias R, Wood EM, Shekleton P, Giles ML (2013) Cytomegalovirus in pregnancy: to screen or not to screen. BMC Pregnancy Childbirth 13:96

    Article  PubMed  PubMed Central  Google Scholar 

  34. Foulon I, Naessens A, Foulon W, Casteels A, Gordts F (2008) A 10-year prospective study of sensorineural hearing loss in children with congenital cytomegalovirus infection. J Pediatr 153:84–88

    Article  PubMed  Google Scholar 

  35. Lanari M, Lazzarotto T, Venturi V et al (2006) Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics 117:e76–e83

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The scientific guarantor of this publication is Prof Jacques Jani. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. This study has received funding by the Fetal Medicine Foundation Belgium. Lei Ding kindly provided statistical advice for this manuscript. Institutional review board approval was obtained. Written informed consent was waived by the Institutional Review Board.

Some study subjects or cohorts have been previously reported in: Foulon I, Naessens A, Foulon W, Casteels A, Gordts F (2008) Hearing loss in children with congenital cytomegalovirus infection in relation to the maternal trimester in which the maternal primary infection occurred. Pediatrics 122:e1123-1127 and Foulon I, Naessens A, Faron G, Foulon W, Jansen AC, Gordts F (2012) Hearing thresholds in children with a congenital CMV infection: a prospective study. Int J Pediatr Otorhinolaryngol 76:712-717. Methodology: retrospective, prognostic study/observational, multicentre study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jacques C. Jani.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOCX 18 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cannie, M.M., Devlieger, R., Leyder, M. et al. Congenital cytomegalovirus infection: contribution and best timing of prenatal MR imaging. Eur Radiol 26, 3760–3769 (2016). https://doi.org/10.1007/s00330-015-4187-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-015-4187-0

Keywords

Navigation